MIRALAX

LOE Approaching

polyethylene glycol 3350

NDAORALFOR SOLUTION
Approved
Oct 2006
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4

Mechanism of Action

Osmotic Activity

Pharmacologic Class:

Osmotic Laxative

Clinical Trials (4)

NCT03060512Phase 4Completed

To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation

Started Mar 2017
276 enrolled
Opioid Induced Constipation
NCT02292459Phase 3Withdrawn

Efficacy and Safety of Polyethylene Glycol 3350 (PEG 3350) for Relief of Constipation (MK-8114-005)

Started Dec 2015
0
Constipation
NCT01707667Phase 4Completed

Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon Activity

Started Feb 2013
13 enrolled
Chronic Constipation
NCT01212445Phase 2Completed

Dose-Finding Trial of Polyethylene Glycol 3350 Laxative Plus Electrolytes for the Treatment of Constipation (Protocol P07515)

Started Oct 2010
154 enrolled
Constipation